University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants in Resource-Limited Settings: Towards Universal Access

Get This Resource

English: PDF [1.2MB]


Since WHO issued revised guidelines in 2006, important evidence has emerged on the use of antiretroviral (ARV) prophylaxis to prevent MTCT, including during breastfeeding, on the optimal time to initiate antiretroviral therapy (ART) in individuals who need treatment, and on safe feeding practices for HIV-exposed infants. The 2010 revision of the recommendations updated the guidelines to reflect this new evidence regarding use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Rapid Advice publications summarized the changes, but this publication presents in detail the scientific evidence and rationale supporting these recommendations.

Related Resources

Publisher: World Health Organization
Language: English
Format: PDF
Region: Global
Audiences: Program Managers, Doctors/Physicians, Nurses, Physician's Assistants/Nurse Practitioners, Trainers
Literacy level: Medium
Topic Areas: Perinatal Interventions, Antiretroviral Treatment & Complications
Resource Type: Clinical Guidelines